|
Delayed
Japan Exchange
09:17:41 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 7,168.00 JPY | -0.24% |
|
+3.96% | -13.04% |
Company Valuation: Chugai Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,141,311 | 5,540,406 | 8,789,053 | 11,516,953 | 13,565,544 | 11,821,500 | - | - |
| Change | - | -9.78% | 58.64% | 31.04% | 17.79% | -12.86% | - | - |
| Enterprise Value (EV) 1 | 5,669,311 | 5,051,408 | 8,050,071 | 10,520,608 | 13,138,942 | 10,903,864 | 10,656,759 | 10,376,024 |
| Change | - | -10.9% | 59.36% | 30.69% | 24.89% | -17.01% | -2.27% | -2.63% |
| P/E | 20.3x | 14.8x | 27x | 29.7x | 31.3x | 23.2x | 20.5x | 18.2x |
| PBR | 5.17x | 3.89x | 5.41x | 6.06x | 6.7x | 5.24x | 4.59x | 4.01x |
| PEG | - | 0.6x | -2.1x | 1.6x | 2.6x | 1.3x | 1.5x | 1.4x |
| Capitalization / Revenue | 6.14x | 4.4x | 7.91x | 9.84x | 10.8x | 8.49x | 7.77x | 7.1x |
| EV / Revenue | 5.67x | 4.01x | 7.24x | 8.99x | 10.4x | 7.83x | 7x | 6.23x |
| EV / EBITDA | 12.3x | 8.93x | 17.1x | 18.3x | 20.4x | 14.7x | 12.9x | 11.2x |
| EV / EBIT | 13.4x | 9.47x | 18.3x | 19.4x | 21.9x | 15.6x | 13.5x | 11.7x |
| EV / FCF | 35.3x | 27.7x | 21.6x | 47.8x | 71x | 24.7x | 20.8x | 17.5x |
| FCF Yield | 2.83% | 3.61% | 4.63% | 2.09% | 1.41% | 4.04% | 4.8% | 5.72% |
| Dividend per Share 2 | 76 | 78 | 80 | 98 | 272 | 134.9 | 152.5 | 171.6 |
| Rate of return | 2.03% | 2.32% | 1.5% | 1.4% | 3.3% | 1.88% | 2.12% | 2.39% |
| EPS 2 | 184.3 | 227.6 | 197.8 | 235.4 | 263.7 | 309.7 | 351.3 | 395.7 |
| Distribution rate | 41.2% | 34.3% | 40.4% | 41.6% | 103% | 43.6% | 43.4% | 43.4% |
| Net sales 1 | 999,800 | 1,259,946 | 1,111,367 | 1,170,611 | 1,257,900 | 1,392,745 | 1,521,950 | 1,664,393 |
| EBITDA 1 | 459,100 | 565,376 | 470,914 | 573,667 | 643,900 | 741,945 | 826,993 | 929,923 |
| EBIT 1 | 421,900 | 533,309 | 439,174 | 542,002 | 598,800 | 698,210 | 791,140 | 889,325 |
| Net income 1 | 303,000 | 374,429 | 325,472 | 387,317 | 434,000 | 509,575 | 576,828 | 651,169 |
| Net Debt 1 | -472,000 | -488,998 | -738,982 | -996,345 | -426,602 | -917,635 | -1,164,741 | -1,445,475 |
| Reference price 2 | 3,735.00 | 3,368.00 | 5,342.00 | 6,999.00 | 8,243.00 | 7,185.00 | 7,185.00 | 7,185.00 |
| Nbr of stocks (in thousands) | 1,644,260 | 1,645,014 | 1,645,274 | 1,645,514 | 1,645,705 | 1,645,303 | - | - |
| Announcement Date | 2/3/22 A | 2/2/23 A | 2/1/24 A | 1/30/25 A | 1/29/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.98x | 7.38x | 13.86x | 1.98% | 74.8B | |
| 39.62x | 13.42x | 28.51x | 0.5% | 1,258B | |
| 40.43x | 6.79x | 19.09x | 1.93% | 679B | |
| 37.52x | 8.51x | 17.57x | 2.38% | 518B | |
| 20.98x | 5.12x | 12.74x | 2.57% | 390B | |
| 104.15x | 5.94x | 25.33x | 2.32% | 367B | |
| 23.47x | 5.94x | 14.26x | 2.69% | 307B | |
| 24.46x | 4.89x | 13.77x | 1.79% | 293B | |
| 23.75x | 7.3x | 13.55x | 2.19% | 252B | |
| -39.18x | 7.27x | 45.77x | 1.98% | 210B | |
| Average | 29.72x | 7.26x | 20.45x | 2.03% | 435B | |
| Weighted average by Cap. | 36.08x | 8.57x | 21.77x | 1.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4519 Stock
- Valuation Chugai Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
